Page 16 of 17
IM12.1-14 | Thyroid Dysfunction — Assignment
CLINICAL SCENARIO
This assignment asks you to work through a structured clinical problem in thyroid disease. You will be given a clinical scenario (below) and asked to complete five sections covering history, TFT interpretation, investigation planning, management, and prescription writing. The purpose is to integrate the clinical evaluation and pharmacotherapy skills from the Thyroid Dysfunction module and demonstrate that you can translate knowledge into a complete clinical management plan for an individual patient.
Clinical scenario: Mrs Kavitha Rajan, a 36-year-old schoolteacher from Chennai, presents to the general medicine outpatient clinic with a 4-month history of palpitations, progressive weight loss of 8 kg despite increased appetite, heat intolerance, and difficulty concentrating at work. She has a 10-year-old daughter with no known thyroid disease. Her menstrual cycles have become irregular over the past 3 months. She takes no regular medications. She reports that her mother had 'thyroid problems' treated with a tablet. On examination: pulse 118/min irregular; BP 134/76 mmHg; thyroid — a diffuse smooth goitre approximately twice normal size with an audible bruit; mild bilateral proptosis with lid lag; fine tremor of outstretched hands; warm moist skin; mild proximal muscle weakness on standing from a chair. TFTs (laboratory report provided): TSH <0.01 mIU/L; FT4 58 pmol/L; FT3 18 pmol/L.
Instructions
Write your responses under the five section headings provided. Use clear clinical language with named drugs, named tests, and specific values where relevant. Do not copy text from the SDL verbatim — demonstrate integration and clinical reasoning. The clinical scenario is fixed; do not alter patient details. For Section 4, address the actual scenario AND the pregnancy sub-question. For Section 5, write the prescription in standard outpatient format (as you would on a real prescription pad). Word limit: 1,100–1,500 words across all sections.
Length: 1,100–1,500 words across all sections
What to Submit
Section 1: Structured History and Examination Findings
Guidance: Document the structured history for this patient under the following domains: (a) presenting complaint and duration; (b) thyrotoxic symptoms — cardiovascular, gastrointestinal, neuropsychiatric, musculoskeletal, reproductive; (c) hypothyroid symptoms to specifically exclude; (d) relevant past history including goitre, neck irradiation, recent iodine exposure; (e) family history of thyroid or autoimmune disease; (f) drug and allergy history; (g) social history including pregnancy status and contraception. Then document the key examination findings as described in the scenario, highlighting the most diagnostically significant findings and naming the examination technique used to palpate the thyroid gland. Approximately 300 words.
Section 2: TFT Interpretation and Differential Diagnosis
Guidance: State what TFT pattern this represents (classify using the standard seven-pattern framework from the module). Construct a prioritised differential diagnosis listing at minimum: your top diagnosis, one alternative cause of overt thyrotoxicosis, and one condition that must be excluded. For each diagnosis on your list: (a) state the clinical and biochemical features that support it, and (b) identify the single most discriminating test that would confirm or exclude it. Approximately 250 words.
Section 3: Investigation Plan
Guidance: Describe your investigation plan in tiers. Tier 1: the screening test and what you expect it to show (already done). Tier 2: the confirmatory tests to characterise the pattern. Tier 3: aetiology-defining tests — which antibodies and/or imaging would you order, and why, for this specific patient? Include: ECG interpretation (what would you expect, and why is it clinically important in this patient?), a targeted CBC order with your rationale, and thyroid ultrasound with Doppler if indicated. State whether RAIU is indicated in this patient and why or why not. Approximately 200 words.
Section 4: Management Plan
Guidance: Propose a complete management plan for Mrs Kavitha Rajan. Include: (a) antithyroid drug selection — state which drug, starting dose, and frequency, and justify your choice given her clinical features; (b) adjunctive therapy — which additional drug class would you add immediately for symptom control, and at what dose? (c) monitoring plan — when will you recheck TFTs, what are you monitoring for, and what are the two most important adverse effects you will counsel her about? (d) definitive therapy — given the clinical features, which definitive option is preferred for this patient and under what circumstances would you refer? (e) special situation: if Mrs Kavitha were 10 weeks pregnant (a different scenario), how would your drug choice change and why? Approximately 350 words.
Section 5: Prescription Writing
Guidance: Write a complete, legally valid prescription for ONE of the following (your choice, aligned to your management plan): (a) the antithyroid drug you selected, or (b) levothyroxine (if Mrs Kavitha had instead presented with overt primary hypothyroidism at TSH 48 mIU/L and FT4 5 pmol/L, cardiac history absent). Include: patient name and age, date, drug name (generic), dose, frequency, duration or indication for review, your name as prescriber, and a specific patient safety instruction. Approximately 100 words.
Grading Rubric — Thyroid Dysfunction Assignment Rubric
| Criterion | Points | Full-marks descriptor |
|---|---|---|
| Clinical History and Examination Findings (Section 1): Accurately documents a structured thyroid-specific history addressing all relevant domains; examination findings are plausible and complete with correct technique described for thyroid palpation. | 20 pts | History covers all seven thyroid-specific domains with relevant positives and negatives; examination documents thyroid size/consistency/bruit, eye signs, cardiovascular and neurological findings with correct posterior palpation technique described. |
| TFT Interpretation and Differential Diagnosis (Section 2): Correctly interprets the TFT pattern provided; constructs a prioritised differential diagnosis with clear reasoning for the top diagnosis and at least two alternatives with discriminating features. | 25 pts | TFT pattern correctly classified (primary vs secondary; overt vs subclinical; synthesis vs release-type); differential includes at least 3 diagnoses in priority order with specific discriminating features (e.g., TRAb, Doppler, RAIU) cited for each. |
| Investigation Plan (Section 3): Proposes a tiered, sequenced investigation plan with justification for each test ordered and a clear rationale for the sequence chosen. | 15 pts | Tier 1 (TSH screen), Tier 2 (FT4 ± FT3 characterisation), Tier 3 (aetiology — TRAb/anti-TPO/RAIU) clearly described in sequence with justification; additional investigations (ECG, CBC, ultrasound) included with specific indication stated. |
| Management Plan (Section 4): Proposes a clinically appropriate, patient-specific management plan including drug choice, dose, monitoring, and patient counselling; addresses at least one special situation from the case (pregnancy, cardiac disease, agranulocytosis risk, or thyroid emergency). | 30 pts | Drug selected with correct pharmacological rationale (mechanism, monitoring parameters); dose specified using appropriate formula; special situation addressed precisely (e.g., PTU vs carbimazole in pregnancy, low starting dose in IHD, agranulocytosis counselling); patient communication section includes specific counselling points. |
| Prescription Writing (Section 5): Writes a complete, legally valid prescription for the primary drug (levothyroxine or antithyroid drug) in the correct format with dose, frequency, duration, and appropriate safety instruction. | 10 pts | Prescription is complete: patient identifiers, date, drug name (generic), dose, frequency, duration, prescriber signature, and a specific safety instruction (e.g., take on empty stomach 30 minutes before food for levothyroxine; stop immediately if fever/sore throat for carbimazole). |
PEER REVIEW
Review your peer's assignment using the rubric. For each section: assign a score from the rubric, and write one specific sentence explaining the score — do not copy rubric descriptors verbatim. For Section 2: verify that the TFT pattern is correctly classified (suppressed TSH + elevated FT4 + elevated FT3 = overt hyperthyroidism) and that the differential is prioritised not merely listed. For Section 4: check that the pregnancy sub-question correctly identifies PTU as the first-trimester choice and notes the switch to carbimazole in trimester 2 — both elements must be present for full marks. For Section 5: check the prescription format against the five required elements and flag any that are missing. Complete your review within 72 hours of receiving the submission.